University of California San Francisco
Give to UCSFUCSF researchers found that distributing pro-COVID-19 vaccine information in EDs in English and Spanish increased vaccine acceptance, especially among Latinos and those without primary care physicians.
Angela Phillips, PhD, leads research that could help predict future viruses like COVID and the antibodies we might use to treat them.
Balyn Zaro’s lab investigates the cause and consequence of genetic diversity in the immune system, in hopes that her discoveries can lead to better treatments for all patients.
Diane Havlir, MD, UCSF’s Weiss Professor, an AIDS pioneer, and an infectious disease leader, is partnering with the local Latinx community to protect vulnerable San Franciscans from COVID-19 and other diseases.
California prisons saw more than 20,000 COVID-19 Omicron cases over a five-month period. However, vaccination and boosting kept hospitalization and death rates low.
The California Collaborative for Pandemic Recovery and Readiness Research (CPR3) at UCSF will investigate the effects of the pandemic on California communities and individuals.
Since March 2020, UCSF has partnered with government and community groups to address racial, economic and cultural barriers to provide equitable care to vulnerable people during the COVID-19 pandemic.
38 UCSF researchers rank in the top 1 percent for impact in their fields, according to a new analysis of research citations by science and intellectual property company Clarivate.
Risk of death or hospitalization from COVID-19 were found to be greater for patients with PTSD.
Researchers have identified specific immune cells that drive deadly heart inflammation in a small fraction of patients treated with powerful cancer immunotherapy drugs.
UCSF Benioff Children’s Hospitals experts weigh in on what RSV is and why we’re seeing so many cases.
Nevan Krogan, PhD, director of UC San Francisco’s (UCSF) Quantitative Biosciences Institute (QBI) and founder of QBI’s Coronavirus Research Group (QCRG), has been awarded the Legion of Honor, France’s highest honor, in a ceremony in Paris.
Nevan Krogan, PhD, director UCSF’s Quantitative Biosciences Institute (QBI) and founder of QBI’s Coronavirus Research Group (QCRG), has been awarded the Legion of Honor, France’s highest honor, in a ceremony in Paris.
A new diagnostic method that applies machine learning to advanced genomics data from both microbe and host to identify and predict sepsis cases was developed by researchers at UCSF, the Chan Zuckerberg Initiative, and CZ Biohub.
Cystic fibrosis is missed more often in newborn screenings for non-white than white babies, creating higher risk for irreversible lung damage and other serious outcomes in Black, Hispanic, Asian, American Indian and Alaska Native newborns.
Scientists at UCSF have developed a new way of looking at sex-biased diseases that is rooted in evolutionary biology.
A new UCSF study researchers of more than 23 million people concludes that some commonly used and abused drugs pose previously unidentified risks for the development of atrial fibrillation (AF), a potentially deadly heart-rhythm disorder.
Three UCSF faculty members are among the 100 new national members elected this year to the National Academy of Medicine (NAM), one of the highest honors in the fields of health and medicine.